Analyst Daniel Brennan works at COWEN and is focused on Healthcare, Basic Materials sectors with 231 price targets and ratings documented since 2013 spanning on 18 stocks. Previously, Daniel Brennan worked at UBS, MORGAN STANLEY. Analyst's average stock valuation to be materialised ratio is 65.67% with an average time for price targets to be met of 147.37 days.
Most recent stock forecast was given on AVTR, Avantor, Inc at 14-Sep-2022.
Daniel Brennan best performing recommendations are on NVTA (INVITAE CORPORATION).
The best stock recommendation documented was for NVTA (INVITAE CORPORATION) at 7/26/2022. The price target of $2 was fulfilled within 1 day with a profit of $0.06 (3.09%) receiving and performance score of 30.93.
Average potential price target upside
Currently, out of the existing stock ratings of Daniel Brennan - 2641 which are a Buy (70.61%), 162 which are a Sell (4.33%), 937 which are a Hold (25.05%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
70
$-7.7 (-9.91%)
5 months 10 days ago
2/2 (100%)
$7.92 (15.45%)
46
Hold
80
$11.56 (16.89%)
85
7 months 9 days ago
10/12 (83.33%)
$1.68 (2.08%)
57
Buy
87
$9.3 (11.97%)
85
10 months 26 days ago
13/16 (81.25%)
$9.12 (18.24%)
210
Buy
86
$8.3 (10.68%)
91
1 years 1 months 17 days ago
8/10 (80%)
$4.45 (13.19%)
240
Buy
85
$7.3 (9.40%)
56
1 years 1 months 17 days ago
3/4 (75%)
$8.91 (20.44%)
372
